APJ, a member of the human G protein-coupled seven-transmembrane receptor family, has been shown to serve as a coreceptor for the entry of human immunodeficiency virus type I (HIV-1) and simian immunodeficiency virus (SIV), and it is dramatically expressed in central nervous system (CNS)-based cells. In this study, expression of APJ tagged with the green fluorescent protein (GFP) and a fluorescent peptide, 5-carboxyfluorescein (5-CF) conjugated Apelin-13, were utilized for studying receptor internalization and recycling, in stably expressing indicator cells, human neurons, primary CNS microvascular endothelial cells (MVECs), and astrocytes. Fusion of the C-terminus of APJ to the N-terminus of GFP did not alter receptor ligand binding and functions, including signaling and internalization. Using 293 cells stably expressing APJ-GFP, we demonstrated that rapid internalization of the APJ receptor was induced by stimulation with Apelin-36 and Apelin-13, in a dose-dependent manner. Furthermore, investigations showed that the internalized APJ was colocalized with transferrin receptors, suggesting that the internalization of APJ induced by Apelin is likely to be via clathrin-coated pits. Interestingly, we found that the internalized APJ molecules were recycled to the cell surface within 60 min after removal of Apelin-13, but most of the internalized APJ still remained in the cytoplasm, even 2 h after washout of Apelin-36. The intact cytoplasmic C-terminal domain was found to be required for ligand-induced APJ internalization. Human neurons were dramatically stained by the APJ-binding fluorescent peptides. Primary human fetal astrocytes were less strongly labeled with 5-CF-Apelin-13, and in primary human CNS MVECs only weak distribution of green fluorescence specific for APJ in the cytoplasm was observed. Apelin-36 blocked cell membrane fusion mostly due to steric interference, with only a very modest effect on receptor internalization. The CNS represents a unique reservoir site for HIV-1. As such, molecular therapeutics and small molecular inhibitors of HIV-1 entry via this unique CNS receptor are now able to be rationally designed.
Introduction
APJ, also known as angiotensin receptor-like (AGTRL1), is a member of the G protein-coupled, seventransmembrane receptor family and was first identified from human genomic DNA by O'Dowd et al. (1993) . Studies with Northern blot analysis and in situ hybridization indicated that APJ mRNA was detected in the central nervous system (CNS), including regions of the hippocampus, striatum, thalamus, cortex, and cerebellum (Edinger et al., 1998; Matsumoto et al., 1996; O'Dowd et al., 1993) . Recent research utilizing immunocytochemical staining with a polyclonal anti-APJ antibody and reverse transcriptasepolymerase chain reaction (RT-PCR) showed that APJ was expressed at a high level in neurons and oligodendrocytes and at lower levels in astrocytes, suggesting that the APJ receptor may play certain important physiological roles in the CNS .
The endogenous peptidic ligand for APJ receptor, Ape-lin, was first isolated from bovine stomach extracts (Tatemoto et al., 1998) . Subsequently, the protein sequences of human, rat, and mouse Apelin pre-pro-proteins were deduced from the cDNAs (Habata et al., 1999; Hosoya et al., 2000; Lee et al., 2000; Tatemoto et al., 1998) . The mature Apelin peptide consisting of 36 amino acid residues (Apelin-36) and the shorter C-terminal peptide with 13 amino acid residues (Apelin-13) were demonstrated to induce signaling responses in APJ-transfected cells and neural cells Hosoya et al., 2000) . In a rat model, Apelins were found to play an important role in the hypothalamic regulation of water intake Reaux et al., 2001; Taheri et al., 2002; ) , and to lower blood pressure via a nitric oxide-dependent mechanism Tatemoto et al., 2001) . It is well-known that entry of human immunodeficiency virus type I (HIV-1) into target cells requires binding of the virus envelope glycoprotein (gp120) to CD4, followed by interactions with a seven-transmembrane receptor as a viral coreceptor. All primary HIV-1 strains use the chemokine receptor CCR5 (M-tropic), CXCR4 (T-tropic), or both (dual-tropic) as major coreceptors Deng et al., 1996; Doranz et al., 1996; Dragic et al., 1996; Feng et al., 1996) . Recent studies have shown that the APJ receptor is employed by T-tropic, M-tropic, dual-tropic HIV-1 and simian immunodeficiency viruses (SIV) for supporting envmediated membrane fusion or viral entry in vitro Edinger et al., 1998; Puffer et al., 2000; Singh et al., 1999; Zhang et al., 1998) . It was reported that some brain-derived viruses also use APJ as a coreceptor (Albright et al., 1999; Shieh et al., 1998) . With the detection of expression of APJ in the CNS, these observations suggested that the APJ receptor might play an important role in HIV-1 infection and pathogenesis in the CNS. Apelin, the natural ligand of APJ, has been found to be able to block the activity of APJ as an HIV-1 coreceptor (Cayabyab et al., 2000; Puffer et al., 2000; Zou et al., 2000) . G-proteincoupled receptors (GPCR), such as CCKAR , CXCR4 (Amara et al., 1997; Orsini et al., 1999; Tarasova et al., 1998) , CCR5 (Mack et al., 1998) , and CCR3 (Zimmerman et al., 1999) , can be induced to undergo rapid internalization upon binding of agonists. In general, such ligand-induced receptor internalization regulates the number of functionally active GPCRs on the plasma membrane. Previous studies have shown that entry of HIV-1 into target cells is independent of the ability of the coreceptor to internalize (Aramor et al., 1997; Doranz et al., 1996; Heveker et al., 1998) . The internalization of coreceptors contributes to chemokine inhibition of virus entry (Amara et al., 1997; Mack et al., 1998; Signoret et al., 1997) , but transient down-regulation of the coreceptor(s) may not be the most efficient way of blocking HIV-1 infection in vivo (Stauber et al., 1999) . Certain viral envelope gp120s were reported to bind to CXCR4 and to induce rapid internalization of cellsurface CXCR4, both in the presence and in the absence of CD4 .
Although APJ is identified as a coreceptor for HIV-1 fusion and infection, little is known about the internalization and recycling of this receptor. In the present study, we used an APJ-GFP fusion protein and a 5-carboxyfluorescein (5-CF)-conjugated Apelin-13 to characterize the internalization and recycling of APJ receptor upon stimulation with natural ligands, a phorbol ester (phorbol myristate acetate: PMA), and HIV-1 gp120s in transfected cells and primary human cells. We also investigated the role internalization of the APJ coreceptor plays in HIV-1 infection and in ligand inhibition of virus fusion and infection.
Results

Expression and function of APJ-EGFP and APJ329-EGFP
To investigate the internalization of the APJ receptor, we constructed two expression vectors, pAPJ-EGFP and pAPJ329-EGFP, consisting of the human APJ receptor and a C-terminally truncated APJ, respectively, both fused to the enhanced version of the green fluorescent protein (EGFP) at the C-terminus. The stably expressing 293 cell lines were established for characterizing the function of APJ-EGFP and APJ329-EGFP. To determine the effects of APJ-EGFP and APJ329-EGFP on signal transduction in response to Apelin-36, we measured intracellular Ca 2ϩ mobilization in stably transfected 293 cells upon stimulation with 3 M Apelin-36. It was demonstrated that APJ-EGFP maintained signaling activity comparable to wild-type APJ, whereas a lower intensity Ca 2ϩ response was observed for APJ329-EGFP (Fig. 1a) . The gene reporter fusion assay was also utilized to evaluate the HIV-1 coreceptor activity of both APJ-EGFP and APJ329-EGFP. Compared to APJ, both fusion proteins exhibited similarly high levels of luciferase activity (Fig. 1b) , suggesting that the EGFP fusion protein did not alter the HIV-1 coreceptor activity of APJ.
Ligand-induced internalization of APJ-EGFP
The EGFP fusion protein at the C-terminus made it possible to assess the ligand-induced internalization of the APJ receptor in stably expressing 293 cells by fluorescence microscopy. In the absence of peptide ligands, APJ-EGFP primarily localized to the cell surface (Fig. 2a) . After exposure to 2 M Apelin-13 or Apelin-36 at 37°C for 30 min, the receptor was dramatically redistributed in the cytoplasm with distinct perinuclear accumulation. The localization of APJ-EGFP was not altered by 200 nM SDF-1␣ (Fig. 2a) , which in the same concentration could induce significant internalization of the human chemokine receptor, CXCR4 (Fig. 2b) .
To further characterize internalization of APJ, cell-surface expression of APJ in stably expressing 293 cells upon exposure to Apelins was analyzed by flow cytometry, with the anti-APJ monoclonal antibody, MB856. The internal-ization of APJ was induced rapidly upon treatment with Apelin-13 and Apelin-36. This effect was already detectable 5 min after Apelin stimulation and reached a maximum after 30 min (Fig. 2c) . APJ internalization was induced by Apelins in a dose-dependent manner, and approximately 50% of cell-surface APJ was internalized by Apelins at 2 M (Fig.  2d ). Apelin-13 and Apelin-36 showed no difference in dosedependence and kinetics in inducing APJ internalization.
Colocalization of internalized APJ-EGFP with transferrin
To investigate the intracellular route of internalized APJ, the APJ-EGFP stably expressing 293 cells and CHO cells were treated with human transferrin coupled to tetramethylrhodamine, which marks early endosomes, or LysoTracker Red, which is taken up into lysosomes. In both 293 and CHO cells, upon stimulation with Apelin-13 and Apelin-36, the internalized APJ-EGFP was primarily colocalized with transferrin and appeared as yellow spots (Fig. 3 ). In contrast, the cells treated with LysoTracker Red revealed no overlap of green and red colors. Taken together, these results indicate that the internalized APJ-EGFP by Apelins is associated with early endosomes.
Recycling of internalized APJ to the cell surface
The recovery of internalized APJ receptor to the cell surface was investigated using the APJ-EGFP stably expressing 293 cells. After stimulation with 2 M Apelin-13 or Apelin-36 at 37°C for 30 min, cells were washed thoroughly with medium and incubated for the time periods indicated. To inhibit the de novo protein synthesis, cells were always incubated in the presence of cycloheximide. The results are shown in Fig. 4 . After removal of Apelin-13, the internalized APJ-EGFP was partly recycled to the cytoplasmic membrane within 30 min of incubation. Further (strain, 89.6) . Cell mixtures were maintained at 37°C for 4 to 6 h. Cell fusion was determined by a luciferase assay. Values are expressed as luciferase activity (RLU/s). All experiments were repeated at least three times, and results are expressed as the mean value Ϯ SE. incubation resulted in full recovery of internalized APJ-EGFP to the cell surface, whereas after washout of Apelin-36, the internalized APJ-EGFP was still maintained in the cytoplasm, even after 120 min of incubation.
Role of the C-terminus of APJ in ligand-induced internalization
We constructed a C-terminally truncated APJ, fused to EGFP at its C-terminus, and transfected the moiety into 293 cells, for establishing a stable expressing cell line. The cell-surface expression, and activity as a coreceptor for HIV-1, of APJ329-EGFP was comparable to APJ-EGFP, but intracellular calcium mobilization in response to Apelin-36 was much weaker than with APJ-EGFP. To investigate the role that the APJ C-terminus plays in ligandinduced internalization, the stably expressing cells were plated onto two chamber slides overnight, and treated with ligands at 37°C for 30 min. Unlike in Fig. 2 which demonstrates that exposure to Apelin-36 caused a dramatic internalization of APJ-EGFP, Apelin-36 did not affect cellsurface localization of APJ329-EGFP (Fig. 5 ). Of note, C-terminus truncation of CXCR4 also ablates internalization with SDF-1 (data not illustrated).
Internalization of 5-CF-Apelin-13 in human astrocytes, brain MVECs, and mature neurons
As reported previously ; the APJ receptor is expressed at high levels in neurons and oligodendrocytes and at lower levels in astrocytes, but these primary cells are difficult to transfect with APJ-EGFP. Thus, a fluorescent peptide ligand, 5-CF-conjugated Apelin-13, was developed to further study the internalization of the APJ receptor in primary human cells and cultured neurons. First, we examined the binding and internalization of this fluorescent peptide in APJ stably transfected 293 cells. As shown in Fig. 6 , the cell surface was stained with the fluorescent peptide after treatment with 5 M 5-CF-Apelin-13 at 4°C for 30 min. Of note, the green fluorescence was distributed in the cytoplasm upon incubation with 5-CF-Apelin-13 at 37°C for 30 min. The same treatment of C-terminally truncated APJ stably expressing 293 cells, with 5-CF-Apelin-13, resulted in no distribution of fluorescent peptides in the cytoplasm. Cells lacking APJ, as negative controls, routinely lacked fluorescence in these studies (not illustrated). These results indicated that 5-CF-Apelin-13 binds to APJ and internalizes into the cytoplasm, together with the receptor. The primary CNS cells, human MVECs, astrocytes, and cultured mature human neurons, differentiated from the NT2 cell-line, were also used for studying internalization of this fluorescent peptide. After incubation with 5 M fluorescent Apelin-13 at 37°C for 40 min, astrocytes were clearly but relatively weakly labeled with green 5-CF-Apelin-13 in the cytoplasm, while a dense green fluorescence in the entire cell was observed in differentiated NT2 cells, which grow in culture in densely packed multicellular "balls" (Mukhtar and Pomerantz, 2000) . In human brain MVECs, little distribution of fluorescent peptide in the cytoplasm was observed (Fig. 6) .
Effects of PMA and the HIV-1 envelope glycoprotein gp120 on APJ internalization
It has been shown that CXCR4 and CD4, but not CCR5, are internalized from the cell surface in response to phorbol ester stimulation Signoret et al., 1997 Signoret et al., , 1998 . We examined the effect of PMA on internalization of Fig. 4 . Recovery of internalized APJ to the cell surface. The stable APJ-EGFP expressing cells were first incubated for 30 min at 37°C with 2 M Apelin-13 or Apelin-36. After internalization, ligands were removed by washing with medium, and the cells were further cultured in medium in the presence of 100 g/ml cycloheximide at 37°C for various periods of the indicated times and then examined for APJ expression. The data shown are representative of at least three independent experiments. the APJ receptor. The stimulation of stably expressing 293 cells with 5 M PMA at 37°C for 30 and 60 min resulted in apparent receptor internalization of CXCR4-EGFP, but PMA treatment at the same concentration did not affect APJ-EGFP localization on the cell surface, as illustrated in Fig. 7a . Thus, APJ is similar to CCR5 and not CXCR4 in this respect.
We also examined the potential of different HIV-1 envelope protein gp120s toward inducing APJ internalization. We treated the 293 cells, which stably express APJ-EGFP, with recombinant gp120s from the dual-tropic isolates 89.6 and SF2, T-tropic isolate MN, and M-tropic isolate Bal, but as indicated in Fig. 7b , none of these viral isolates' envelopes induced APJ internalization, as compared to the strong internalization of APJ induced by treatment with Apelin-36 (3 M).
Role of APJ internalization in ligand blocking of HIV-1 infection
As demonstrated above (Fig. 2) , the ability of Apelin-13 to induce receptor internalization showed no difference as compared to Apelin-36. To determine the activity of Apelin-13 and Apelin-36 in blocking HIV-1 entry, we first used a gene reporter fusion assay to examine the ability of both peptides toward inhibition of cell-cell fusion, involved with the APJ receptor and HIV-1 89.6 gp120. Before initiation of fusion, the target cells were incubated in the presence or absence of the test Apelin at 37°C for 30 min, resulting in sufficient APJ receptor molecules on the cell surface for internalization. Nonetheless, the fusion data showed that treatment with Apelin-36 led to blocking of cell-cell fusion in a dose-dependent manner, whereas addition of Apelin-13 resulted in no inhibitory activity (Fig. 8a) , suggesting that receptor internalization may not associate with ligand inhibition of HIV-1 entry, at least for APJ as a coreceptor.
Since Apelin-36 was demonstrated to induce APJ internalization and prevent recycling to the cell surface, and to further confirm the role of receptor internalization in inhibition of HIV-1 entry, we transfected 293-CD4 cells with APJ and APJ329 for cell fusion assays to study the effects of Apelin-36 on inhibition of cell membrane fusion. As shown in Fig. 8b , cell membrane fusion was inhibited by addition of Apelin-36 in a concentration-dependent manner for both wild-type APJ and the C-terminally truncated APJ, and fusion inhibition by Apelin-36 was somewhat, but not significantly, more efficient in wild-type APJ transfected cells, as compared to APJ329-transfected cells.
Discussion
The APJ receptor is widely expressed in the human CNS Edinger et al., 1998; Matsumoto et al., 1996; O'Dowd et al., 1993) . APJ and its natural ligand, Apelin, may play an important role in the hypothalamic regulation of water intake in the endocrine axis Reaux et al., 2001; Taheri et al., 2002) , and in lowering blood pressure via a nitric oxide-dependent mechanism Tatemoto et al., 2001) . Recently the APJ receptor has been identified as a coreceptor for HIV-1 and SIV for supporting env-mediated membrane fusion or viral entry in vitro and possibly in vivo Edinger et al., 1998; Puffer et al., 2000; Singh et al., 1999; Zhang et al., 1998) . In this study, our aim was the molecular characterization of internalization of APJ receptor in transfected cells with APJ C-terminally fused with EGFP, and in human astrocytes, CNS MVECs and cultured human neurons with a fluorescent peptide ligand. We also evaluated the role of APJ internalization in ligand inhibition of virus entry.
The green fluorescent protein (GFP) has been widely used to construct chimeric proteins to study their localization, distribution, and function in different systems. Previous studies have demonstrated that fusing GPCR with GFP at the C-terminus led to a fully functional CCKAR (Tarasova et al., 1997), ␤ 2 -Adrenergic receptor (Barak et al., 1997) , and CXCR4 (Tarasova et al., 1998) . For this study, we constructed a chimeric APJ C-terminally fused with EGFP and established stably expressing cell lines. Compared to the wild-type APJ receptor, APJ-EGFP was found to have normal signaling and HIV-1 gp120-induced cell membrane fusion. The expression of APJ-EGFP allows us to easily detect the receptor moiety under fluorescence microscopy, for further characterizing receptor internalization and recycling. In response to Apelins, the cell-surface APJ-EGFP was rapidly internalized in a dose-dependent manner. To further investigate the fate of internalized APJ, the cells expressing APJ-EGFP were costaining with tetramethylrhodaminetransferrin or LysoTracker Red. We found that the internalized APJ molecules were colocalized with transferrin, a marker for early endosomes (Ghosh and Maxfield, 1995) , suggesting that the internalization of APJ induced by Apelins is likely to be via clathrin-coated pits. Previous studies have shown that the internalized cholecystokinin receptors and CCR5 (Ghosh and Maxfield, 1995) accumulate in early endosomes and recycle with almost 100% efficiency to the cell surface. CXCR4 has been found to target to lysosomes after SDF-1-induced internalization and to be poorly recycled to the cell surface (Signoret et al., 2000; Tarasova et al., 1998 ). Here we found that although Apelin-13 and Apelin-36 have the same potential in inducing receptor internalization, internalized APJ mol- ecules by treatment with Apelin-13 were recycled to the cell surface within 60 min, while APJ receptors internalized by Apelin-36 still remained in the cytoplasm even after a 60 min incubation. It has been found that the range of recycling times for other GPCRs is between 20 to 60 min (Ashworth et al., 1995; Marchese and Benovic, 2001; Tarasova et al., 1997) . In our recycling experiments, we incubated the cells at 37°C for 120 min after removal of Apelin-36, but most internalized receptors still remained in the cytoplasm. Mack et al. (1998) have demonstrated that aminooxypentane-RANTES (AOP-RANTES) efficiently induces internalization of CCR5 and, unlike wild-type RANTES, prevented recovery of CCR5 to the cell surface. The mechanism through which Apelin-36 and AOP-RANTES prevented recycling of internalized receptors to the cell surface remains unclear. It has been established that recycling of internalized receptors needs to be proceeded by receptor dephosphorylation (Grady et al., 1995 Krueger et al., 1997 . Signoret et al. (2000) found that sustained binding of AOP-RANTES prevents CCR5 recycling. The receptor-bound Apelin-36 was demonstrated to be barely dissociated from the APJ receptor . It is possible that the bound Apelin-36 may block dephosphorylation of the internalized APJ and recycling to the cell surface.
It has been shown previously that serine and threonine residues in the C-terminal domain of GPCRs are critical for ligand-induced internalization (Benya et al., 1993; Innamorati et al., 1999; Maestes et al., 1999; Pizard et al., 1999; Roth et al., 1997) . C-terminally truncated CXCR4, CCKBR, and IL-8 receptor B were found to be expressed and function as wild-type, but the ligand-induced internalization was severely impaired (Amara et al., 1997; Lamey et al., 2002; Maestes et al., 1999; Signoret et al., 1997) . To examine the function of the APJ C-terminus in receptor internalization, we constructed and APJ mutant with deletion of the Cterminus and created a stably expressing cell line. We found that the mutant APJ in stable cells appeared the same as wild-type by expression levels and coreceptor activity, but the signaling in response to stimulation with Apelins was severely impaired, and ligand-induced internalization was totally blocked. These results are in agreement with previous studies with CCR5 (Alkhatib et al., 1997; Prado et al., 1996) . However, further studies will be needed to identify the determinants in the C-terminal domain of APJ involved in ligand-induced internalization. For the APJ receptor, treatment with PMA had no effect on receptor internalization. Shin et al. demonstrated that the motif SQIKRLL in the C-terminal domain of CD4 was involved in phorbol ester-induced internalization (Hoxie et al., 1998) . A similar motif, SSLKIL, in CXCR4 was found to be responsible for internalization induced by PMA . Of note, APJ and CCR5 do not have such a motif in the C-terminal domain. As such, this may be the reason that APJ and CCR5 are not internalized by phorbol ester treatment.
Recently, it has been reported that APJ functions as a coreceptor for the primary T cell tropic isolates HIV-1 (ELI) and HIV-1 (UG21), the dual-tropic strain HIV-1 (89.6), and to a lesser extent with the T cell line adapted isolates HIV-1 (MN) and HIV-1 (HXB2), and SIV (mac-316) Edinger et al., 1998; Puffer et al., 2000; Singh et al., 1999; Zhang et al., 1998) . The viral envelope glycoprotein, gp120, has been reported to bind to CXCR4 and to induce rapid internalization of cell-surface CXCR4, both in the presence and in the absence of CD4 (Tarasova et al., 1998) . Our results showed that the viral envelope proteins were unable to induce internalization and signaling of the APJ receptor, although these viruses use APJ as a coreceptor to infect human cells, suggesting that the viral envelope gp120 binds to APJ at different sites from Apelin ligands.
The APJ receptor is expressed in human neurons, oligodendrocytes, and astrocytes . Thus, it is important to examine the internalization of APJ receptor in primary human CNS cells and neurons in culture. In this study, a fluorescent peptide Apelin was developed to directly probe APJ internalization in primary human brain MVECs, astrocytes, and cultured human neurons (i.e., fully differentiated NT2 cells). Although 5-CF-Apelin-13 bound to APJ with lower affinity than Apelin-13, the green fluorescence was distributed in the cytoplasm upon incubation with 5-CF-Apelin-13. Previous studies have demonstrated that Apelin-36 binds to APJ with higher affinity than Apelin-13 (Shin et al., 1990) , but Apelin-13 is found to be more active in suppression of cAMP production, promotion of acidification rates, and chemotaxis for CHO-A10 cells, as compared to Apelin-36 (Habata et al., 1999; Hosoya et al., 2000; Shin et al., 1990) , indicating that for APJ, binding affinity is not critical for Apelin-induced receptor function. When the fluorescent peptides were applied to primary human CNS cells and cultured neurons, differences of distribution of fluorescent peptides in the cytoplasm was observed among MVECs, astrocytes, and neurons. Neurons were robustly and completely stained by green fluorescence, while astrocytes were less strongly labeled with 5-CF-Apelin-13. In MVECs, very weak distribution of fluorescent peptides in the cytoplasm was observed. These initial results were consistent with observations of APJ expression in these cells. However, this fluorescent peptide provides us with an excellent tool to further investigate APJ internalization and recycling in primary human CNS cells and cultured neurons. CXCR4 and CCR5 are the two main coreceptors for the entry of HIV-1 into human cells (Deng et al., 1996; Kawamata et al., 2001 ). The natural ligands for CXCR4: SDF-1␣, and for CCR5: RANTES, MIP-1␤, and MIP-1␣, inhibit the entry of certain HIV-1 strains into cells (Bleul et al., 1996; Choe et al., 1996; Kawamata et al., 2001 ). Although initial studies suggest that the observed HIV-1 suppressive effects of chemokine antagonists are due to competitive inhibition of gp120 binding to the coreceptors (Arenzana-Seisdedos et al., 1996; Cocchi et al., 1995) , recent studies with CXCR4 and CCR5 have demonstrated that coreceptor internalization contributes to chemokine inhibition of virus entry (Amara et al., 1997; Prado et al., 1996; Signoret et al., 1997) . Apelins have been found to be able to block the activity of APJ as an HIV-1 coreceptor (Cayabyab et al., 2000; Puffer et al., 2000; Zou et al., 2000) . However, the mechanism by which Apelins block APJ-dependent cellmembrane fusion and virus entry is still unclear. In the present study, we found that Apelin-36 inhibited cell-membrane fusion, involved with APJ and the 89.6 isolate gp120, more efficiently than Apelin-13. We do not know whether the higher efficiency in inhibition of cell-cell fusion with Apelin-36 is due to higher binding affinity (Shin et al., 1990) , or to the prevention of recycling of internalized receptors. To further evaluate the role of receptor internalization in inhibition of HIV-1 entry, we compared the efficacy of Apelin-36 in blocking cell fusion in wild-type and C-terminally truncated APJ. We found that although Apelin-36 inhibited cell-membrane fusion in both wild-type and truncated APJ-expressing cells, the activity of Apelin-36 in blocking cell membrane fusion was slightly more efficient in APJ-transfected cells than in cells expressing C-terminally truncated APJ. These results suggested that inhibitory activity of Apelin-36 in cell membrane HIV-1 fusion was mainly due to steric interference, and receptor internalization only slightly contributed to efficient ligand blocking of virus entry.
In summary, this is the first report to use fusion constructs of the APJ receptor with EGFP at the C-terminus and fluorescent peptide Apelin-13 to characterize the ligandinduced internalization of APJ in transfected cells and in primary human CNS cell types. We found that a rapid internalization of APJ receptor was induced by stimulation with Apelin-36 and Apelin-13, in a dose-dependent manner. The internalized APJ was colocalized with transferrin receptors. Interestingly, we demonstrated that the internalized APJ were recycled to the cell surface within 60 min after removal of Apelin-13, but most of the internalized APJ still remained in the cytoplasm even 2 h after washout of Apelin-36. Neurons were completely stained by fluorescent peptides, and astrocytes were less intensely labeled with 5-CFApelin-13, while in MVECs, only very weak distribution of green fluorescence in the cytoplasm was observed. Apelin-36 blocked cell membrane fusion with gp120 mainly due to steric interference. Further studies in model blood:brain barrier (BBB) systems with primary human CNS cell types expressing APJ will be necessary to extend these initial analyses (Mukhtar and Pomerantz, 2000) . Tissue levels of the Apelins throughout the CNS in vivo should now be more broadly studied to determine if they may have some inhibitory effects on HIV-1 infections.
Understanding the relatively enigmatic APJ chemokine coreceptor will assist in dissecting the molecular parameters of HIV-1 neuropathogenesis. These data, and studies on other key chemokine coreceptors (Zhou et al., 2001) , are necessary in the rational design of molecular and pharmacological therapeutics to combat HIV-1 infection in the CNS and lentiviral neuroinvasion.
Materials and Methods
Materials
Dulbecco's modified Eagle's medium (DMEM), fetal bovine serum, and G418 were purchased from Life Technologies, Inc. Rhodamine red concanavalin A (ConA), tetramethylrhodamine-transferrin, LysoTracker Red, furo-2, and Pluronic F-127 were purchased from Molecular Probes Inc. (Eugene, OR). The plasmid, pCDNA-APJ, recombinant 89.6 gp120, recombinant vaccinia viruses encoding an envelope glycoprotein of HIV-1 vBD3 (89.6), and vTF1.1 encoding T7 RNA polymerase were generous gifts from Dr. 
Cells and cell culture
The human CNS microvascular endothelial cells (MVECs) were obtained from Cell System Corp., Kirkland, WA and grown at 37°C, 5% CO 2 , 100% humidity in human endothelial growth medium. The human fetal astrocytes were purchased from Advanced Bioscience Resources, Inc. (Alameda, CA) and maintained in growth medium including Ham's F12/DMEM with high-glucose fetal calf serum, 1 M HEPES, 7.5% sodium bicarbonate, penicillin-streptomycin(1ϫ), and glutamine. The Ntera2/D1 (NT2) cell line, which is derived from a human teratocarcinoma (Lee and Andrews, 1986) , was obtained from the American Tissue Culture Collection (Rockville, MD). The NT2 cells were maintained and differentiated into fully mature human neurons, as described previously (Mukhtar and Pomerantz, 2000) . The CHO cell line was obtained from the American Type Culture Collection. The 293 cell line was obtained from the AIDS Research and Reference Reagent Program (Division of AIDS, NIAID, NIH). 293 and CHO cells were maintained in DMEM plus 10% fetal bovine serum.
DNA constructions
A C-terminally truncated APJ (APJ329) was constructed by altering codon-330 into a stop codon and mutating serine-319 and serine-312 into alanines by PCR (313-DPRFRQACTSMICCGQSRCAGTSHSSSGEKSASYSS-GHSGPGPNMGKGGEQMHEKSIPYSQETLVVD-CO-OH; 329-DPRFRQACTAMLCCGQA-COOH). The full open reading frames (ORF) of wild-type and C-terminally truncated APJ and CXCR4 were amplified using PCR and subcloned in-frame into HindIII and BamHI sites of pEGFP-N1 vector. All constructs were sequenced to confirm the correct sequences and orientations. The plasmid constructs of wild-type and C-terminus-truncated APJ were transfected into 293 cells by the calcium-phosphate precipitation method. Twenty-four hours after transfection, selection for stably expressing cells was initiated by the addition of G418 (800 g/ml). Transfected cells were evaluated for expression levels of APJ at the cell surface by flow cytometry.
Flow cytometry
Stable APJ transfected 293 cells (2 ϫ 10 5 ) were washed with fluorescence-activated cell sorting (FACS) buffer (0.3% bovine serum albumin, 0.05% sodium azide in PBS) and incubated with an anti-APJ monoclonal antibody (mAb) MAB856 (10 g/ml) for 30 min at 4°C. After washing with FACS buffer, cells were incubated with 10 g fluorescein isothiocyanate (FITC)-conjugated goat anti-mouse IgG (Sigma) for 30 min at 4°C. After washing twice with FACS buffer, cells were fixed in a buffer (2% paraformaldehyde in PBS) and then analyzed on a FACScan flow cytometer (Coulter EPICS Elite, Coolten Corp., Hialeah, FL). For detection of APJ internalization, cells were first incubated with Apelin-13 or Apelin-36 at 37°C for 40 min and then washed with FACS buffer. After staining, cells were analyzed by FACS.
Fluorescence microscopy
The stable APJ or C-terminus-truncated APJ expressing 293 cells were seeded on two-chamber slides (Nunc, Inc.) and incubated at 37°C overnight. After treatment with Apelins or phorbol myristate acetate (PMA), cells were washed in PBS and then fixed in PBS containing 2% paraformaldehyde for 10 min. Fluorescence microscopy was performed on an Olympus System microscope, model BX60, with fluorescence attachment BX-FLA. For time-course studies of APJ-EGFP internalization, the cells were treated with 2 M Apelin-13 or Apelin-36 in the presence of 25 g/ml cycloheximide at 37°C for 30 min. After washing with medium, the cells were incubated at 37°C for various time periods and observed with fluorescence microscopy. For colocalization of APJ-GFP with tetramethylrhodaminetransferrin or LysoTracker Red, the cells were treated with 1 M tetramethylrhodamine-transferrin or 50 nM LysoTracker Red at 37°C for 15 min, rinsed with medium, and incubated with 2 M Apelin-13 or Apelin-36 for different time periods. The cells were finally rinsed with PBS and fixed with 2% paraformaldehyde and then analyzed with fluorescence microscopy.
Intracellular calcium measurements
Utilizing a modified procedure published by others (Donnadieur et al., 1994; Heveker et al., 1998) , untransduced 293 cells and APJ or C-terminus-truncated APJ stably transfected 293 cells were cultured in DMEM containing 10% FBS. Cells were trypsinized and washed twice with PBS. For Ca 2ϩ mobilization studies, 5 ϫ 10 6 cells/ml were loaded with the fluorescent dye, fura-2 (3 M), and 0.05% F172 in Hanks balanced salt solution (140 mM NaCl, 5 mM KCl, 10 mM HEPES pH 7.4, 1 mM CaCl 2 , 1 mM MgCl 2 , 1 mg/ml glucose, and 0.025% BSA), for 30 min at 37°C. The cells were washed three times and resuspended at a concentration of 30 to 40 ϫ 10 6 /ml; then 1.5 to 2 ϫ 10 6 cells were tested in the same buffer. Intracellular Ca 2ϩ mobilization was measured using excitation at 340 and 380 nm on a fluorescence spectrometer (Perkin-Elmer LS50B, Beaconsfield, U.K.), upon stimulation with Apelins. Intracellular Ca 2ϩ concentrations were calculated using a fluorescence spectrometer measurement program.
Gene reporter fusion assay
A gene reporter fusion assay was used to determine the coreceptor activity of APJ in mediating HIV-1 entry, following a modified procedure published by others (Nussbaum et al., 1994; Rucker et al., 1997) . Briefly, the effector 293 cells were infected with recombinant vaccinia virus with HIV-1 Env protein (strain 89.6) and T7 RNA polymerase for 2 h. Infected cells were then trypsinized, washed with PBS, resuspended in medium, and incubated overnight at 32°C in the presence of rifampicin (100 g/ml). Target cells were cotransfected in six-well plates with plasmids encoding CD4, wild-type APJ, and luciferase under the control of the T7 promoter, using the calcium-phosphate precipitation method. Four hours after transfection, cells were detached, seeded in 24-well plates, and incubated at 37°C overnight. Before fusion, the target cells were incubated in the presence or absence of the test Apelin for 30 min. To initiate fusion, 10 5 effector cells were added to each well and incubated at 37°C in the presence or absence of the test Apelin. After 5 h, cells were lysed in 150 l of reporter lysis buffer (Pharmingen) and assayed for luciferase activity by using commercially available reagents (Pharmingen) in a luminometer.
Peptide synthesis
The peptides Apelin-13 and Apelin-36 were prepared by solid-phase synthesis using Fmoc-strategy on a 430A peptide synthesizer (Applied Biosystems, Foster City, CA) and a 9050 Pepsynthesizer Plus (Perseptive Biosystems, Cambridge, MA). Crude peptides were purified by preparative reverse-phase high-performance liquid chromatography using a Dynamax-300Å C 18 25 cm ϫ 21.4 mm i.d. column with a flow rate of 9 ml/min and two solvent systems of 0.1% TFA/H 2 O and 0.1% TFA/acetonitrile. Fractions containing the appropriate peptide were pooled together and lyophilized. The purity of the final product was assessed by analytical reverse-phase high-performance liquid chromatography, capillary electrophoresis, and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
Conjugation of 5-carboxyfluorescein to Apelin-13
Apelin-13, in which the side chain of Lys was protected with (4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)ethyl (dde), was treated with 2% hydrazine in DMF, allowing the selective deprotection of dde group from the side chain Lys. Since hydrazine will remove Fmoc, the N-terminus of the peptide Apelin-13 was protected with Boc. Then, the peptide resin was treated with 5-carboxyfluorescein (2.5 equiv), HBTU (2.5 equiv), HOBT (2.5 equiv), and DIPEA (5 equiv) in DMF (minimum to cover the resin) at room temperature overnight. The coupling was repeated to obtain a negative Kaiser test, if necessary. Final deprotection of all other side chain protecting groups, cleavage from the resin, purification by reversed-phase HPLC, and analytical characterization were carried out, as described above for the corresponding peptide.
